## **Core Concept**
The question tests knowledge on the adverse effects of certain medications, specifically those that can cause proximal tubule proteinuria and painful bone lesions. This combination of symptoms can be associated with medications that affect bone metabolism and renal function.

## **Why the Correct Answer is Right**
The correct answer, **Lithium**, is associated with both proximal tubule proteinuria and painful bone lesions. Lithium can cause nephrogenic diabetes insipidus and proximal tubular damage, leading to proteinuria. Additionally, lithium can cause changes in bone metabolism, leading to hyperparathyroidism and subsequent bone pain due to increased parathyroid hormone levels.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain medications like **Aminoglycosides** can cause proximal tubule damage and proteinuria, they are not commonly associated with painful bone lesions.
- **Option B:** **Bisphosphonates** can cause renal impairment and are used to treat bone diseases like osteoporosis and Paget's disease, but they are not typically associated with causing proximal tubule proteinuria as a primary effect; they can cause renal toxicity but the profile doesn't match as closely.
- **Option C:** **Vitamin D analogues** can affect bone metabolism but are not primarily known for causing proximal tubule proteinuria.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that lithium toxicity can manifest with a wide range of symptoms, including renal effects (like nephrogenic diabetes insipidus and proximal tubule damage) and musculoskeletal effects (like bone pain). Monitoring lithium levels and renal function is crucial in patients on long-term lithium therapy.

## **Correct Answer:** .